N
Patient 1
THIS REPORT IS SUBMITTED ON MARCH 27, 2020.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NUCLEUS CI512 COCHLEAR IMPLANT WITH CONTOUR ADVANCE ELECTRODE | NUCLEUS 24 COCHLEAR IMPLANT SYSTEM | COCHLEAR LTD | MCM | CI512 | NA | NA | N | N |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2020-03-26 | 0 | 1. R |
Patient 1
THIS REPORT IS SUBMITTED ON MARCH 27, 2020.
Patient 1
PER THE CLINIC, THE PATIENT EXPERIENCED AN INFECTION AT THE IMPLANT SITE FOLLOWING THE REMOVAL OF THE INTERNAL MAGNET PRIOR TO AN MRT. THE INFECTION WAS TREATED WITH ORAL ANTIBIOTIC. THE IMPLANT REMAINS IN-SITU.